Access cutting-edge cholestatic liver disease treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access cholestatic liver disease specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cholestatic liver disease treatment provided free
The purpose of this study is to determine whether the investigational treatment (maralixibat) is safe and effective in pediatric and adult participants who have cholestatic liver disease with pruritus that has been refractory to other therapies, and who have no other treatment options.
Sponsor: Mirum Pharmaceuticals, Inc.
Check if you qualify for this cholestatic liver disease clinical trial in Palo Alto, CA
If you're searching for cholestatic liver disease treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cholestatic liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.